5 most recent filings and news items mentioning ELV. Updated every 60 seconds.
BiotechJul 28, 2026Neutral
'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive
View filing at SEC.gov →
MarketsJul 16, 2026Neutral
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It
View filing at SEC.gov →
Earnings|GuidanceJul 15, 2026Positive
Elevance Health reported second quarter 2026 operating revenue of $49.8 billion and adjusted diluted EPS of $7.45, beating expectations. The company raised its fiscal 2026 adjusted diluted EPS guidance to at least $27.00 and operating cash flow guidance to at least $6.0 billion.
View filing at SEC.gov →
MediaJul 15, 2026Neutral
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
View filing at SEC.gov →
NewsJul 8, 2026Neutral
Reported Earlier, 'Obamacare Insurers Seek Big Rate Hikes, Again' - WSJ Exclusive
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.